Pharmaceutical Companies
LakeShore Biopharma Co., Ltd
๐ฐ๐พCayman Islands
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $87.7M
- Website
- -
SYNTHAVERSE S A
๐ต๐ฑPoland
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $87.3M
- Website
- -
Armata Pharmaceuticals
๐บ๐ธUnited States
- Ownership
- Public, Subsidiary
- Established
- 2005-01-01
- Employees
- 66
- Market Cap
- $87M
- Website
- http://www.armatapharma.com
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and...
Tevogen Bio Inc
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $86.9M
- Website
- -
SELLAS LIFE SCIENCES LIMITED
๐ฎ๐ชIreland
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $86.8M
- Website
- -
BioAtla
๐บ๐ธUnited States
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by...
ACLARIS THERAPEUTICS INC
๐ฎ๐ณIndia
Boundless Bio, Inc.
๐บ๐ธUnited States
OS Therapies
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- 4
- Market Cap
- $84.3M
- Website
- -
Ikena Oncology
๐บ๐ธUnited States
Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412,...
